NEW YORK, Oct 31 –Pharmacogenomics technology company Variagenics of Cambridge, Mass., said Tuesday strong revenue growth helped to the company to narrow its third quarter net losses to $6.4 million, or 35 cents a share, compared with losses of $6.6 million, or $10.75 a share a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.